Dr. Griebeler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3733 Park East Dr
Beachwood, OH 44122Phone+1 216-504-0001Fax+1 216-444-9423
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2014
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2007 - 2011
- Hlth Scis Fed Univ Porto AlegreClass of 2004
Certifications & Licensure
- OH State Medical License 2017 - 2027
- SD State Medical License Active through 2019
- MN State Medical License 2011 - 2018
- FL State Medical License 2010 - 2012
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
Publications & Presentations
PubMed
- De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: ...Paloma Rodriguez, Nikki Breslaw, Huijun Xiao, Jim Bena, Kimberly Jenkins
Diabetes, Obesity & Metabolism. 2024-11-12 - Effective but inaccessible antiobesity medications: A call for sharing responsibility for improving access to evidence-based care.Bartolome Burguera, Marcio L Griebeler, W Timothy Garvey
Cleveland Clinic Journal of Medicine. 2024-11-01 - An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in...Kevin M Pantalone, Bruce Rogen, Patty Zirm, Huijun Xiao, James Bena
Diabetes Therapy. 2024-05-01
Press Mentions
- As Obesity Booms, Doctors Seek Additional Treatment OptionsOctober 2nd, 2024
- Doctors Seek Additional Obesity Training in Wake of Obesity Patient BoomOctober 1st, 2024
- People with Diabetes Struggle to Find Ozempic as It Soars in Popularity as a Weight Loss AidJanuary 12th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: